|
Vaccine Detail
P. chabaudi AMA1 Protein Vaccine |
Vaccine Information |
- Vaccine Name: P. chabaudi AMA1 Protein Vaccine
- Target Pathogen: Plasmodium spp.
- Target Disease: Malaria
- Vaccine Ontology ID: VO_0004194
- Type: Subunit vaccine
- Status: Research
- Antigen: Recombinant ectodomain of P. chabaudi adami (DS stain) AMA1 (denoted rAMA1B)
- AMA-1 from P. chabaudi
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Adjuvant:
- Adjuvant name:
- VO adjuvant ID: VO_0001268
- Description: Montanide ISA720
- Immunization Route: Intraperitoneal injection (i.p.)
|
Host Response |
Mouse Response
- Host Strain: BALB/c
- Vaccination Protocol: Groups of three to five mice were immunized i.p. with 15 µg of rAMA1B emulsified in Montanide ISA720. Four weeks later, a booster immunization was given using the same amount of rAMA1B emulsified with Montanide ISA720. Controls were immunized with PBS emulsified in Montanide ISA720 (Xu et al., 2000).
- Challenge Protocol: Ten days after being given a booster immunization the mice were challenged i.v. with 1 x 10^5 P. chabaudi adami parasitized erythrocytes (Xu et al., 2000).
- Efficacy: Immunized mice demonstrated significantly lower peak parasitemias compared with PBS-immunized mice, showing that rAMA1B immunization confers protection against challenge with P. chabaudi (Xu et al., 2000).
|
References |
Xu et al., 2000: Xu H, Hodder AN, Yan H, Crewther PE, Anders RF, Good MF. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization. Journal of immunology (Baltimore, Md. : 1950). 2000; 165(1); 389-396. [PubMed: 10861076].
|
|